Marathon Trading Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,000
Closed -$166K 323
2025
Q1
$166K Buy
+1,000
New +$156K 0.02% 248
2024
Q4
Sell
-500
Closed -$81K 338
2024
Q3
$81K Buy
+500
New +$79.7K 0.01% 233
2023
Q3
Sell
-1,200
Closed -$199K 347
2023
Q2
$199K Sell
1,200
-2,800
-70% -$452K 0.02% 181
2023
Q1
$620K Buy
4,000
+1,300
+48% +$210K 0.05% 125
2022
Q4
$477K Sell
2,700
-3,600
-57% -$622K 0.06% 134
2022
Q3
$1.03M Buy
6,300
+1,800
+40% +$305K 0.1% 103
2022
Q2
$799K Buy
4,500
+3,300
+275% +$588K 0.09% 136
2022
Q1
$213K Buy
+1,200
New +$204K 0.02% 244
2021
Q1
Sell
-31,000
Closed -$4.88M 450
2020
Q4
$4.88M Buy
+31,000
New +$4.57M 0.25% 57
2017
Q1
Sell
-5,000
Closed -$576K 181
2016
Q4
$576K Buy
+5,000
New +$578K 0.07% 83

Other funds holding JNJ

Marathon Trading Investment Management's JNJ Position: Q4 2024 in Review

Marathon Trading Investment Management sold out of Johnson & Johnson (JNJ) in Q4 2024, closing a stake of 244 shares — an estimated $37.8K sold.

Marathon Trading Investment Management first reported a position in JNJ in Q4 2018 and held it in 4 quarters. The position peaked at $918K in Q4 2018. 4,106 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

  • Marathon Trading Investment Management reported no remaining Johnson & Johnson position as of Q4 2024 after selling out during the quarter.
  • Marathon Trading Investment Management sold 244 Johnson & Johnson shares in Q4 2024, an estimated $37.8K.
  • Marathon Trading Investment Management first reported a position in Johnson & Johnson in Q4 2018 and held it in 4 quarters.
  • Marathon Trading Investment Management's Johnson & Johnson position peaked at $918K in Q4 2018.
  • 4,106 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on Marathon Trading Investment Management's 13F filing for Q4 2024, filed 7 Feb 2025.